To Top

Our Mission

WE ARE COMMITTED TO THE DEVELOPMENT OF FIRST-IN-CLASS, EFFECTIVE THERAPIES THAT HARNESS THE POWER OF THE TUMOR MICROENVIRONMENT (TME) TO OVERCOME DRUG RESISTANCE AND IMPROVE TREATMENT OUTCOMES FOR CANCER PATIENTS

Our Pipeline

CM24 NTS219 MI1240
Skip to content